Insights On Facility Design

  1. Three Options To Viral Vector Manufacturing Capacity 9/1/2020

    A recent Virtual Think Tank focused on the challenges and trends influencing design considerations for viral vector manufacturing facilities, and how they can impact companies developing cell and gene therapies.

  2. What You Need To Know Before Investing In A Bioprocessing Space 8/6/2020

    Selecting the bioreactor that is best for your process and the dedicated space you have available requires consideration of many important factors.

  3. 6 Misconceptions About Automating Cell Therapy Manufacturing 6/18/2020

    To help you move into a digitized world, here are six common misconceptions that can potentially hinder your ability to successfully execute an MES for cell therapy.

  4. Never Too Early To Plan For Automation 6/8/2020

    Early platform design selections can greatly affect your future automation flexibility and ability to show compliance throughout regulatory reviews.

  5. Standardization Is Key To Building A Successful Global Business Strategy 4/15/2020

    Standardized approaches to biomanufacturing can lower costs, improve outcomes, and alter the landscape of the global pharmaceutical market.

  6. The Insource Vs. Outsource Dilemma 2/21/2020

    Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for its manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.

  7. Making Data Work 12/16/2019

    What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.

  8. When Clean Is Critical—Understanding Parameters And Definitions Of Clean 11/15/2019

    Clean room environments necessitate high-quality materials and equipment that conform to a variety of specified standards. This white paper explains how clean parameters are defined and validated.

  9. Flexible Manufacturing: Better, Faster Virus Production 11/7/2019

    The global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.

  10. Automating Cell Therapy Manufacturing For GMP Compliance And Consistency 11/1/2019

    Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.